Ipigrix solution for injections 15 mg/ml. 1ml. ampoules №10

Description

Ipigrix №10 Composition
active substance: ipidacrine (ipidacrine)

1 ml solution (1 ampoule) 5 mg or 15 mg ipidacrine hydrochloride monohydrate (in terms of ipidacrine hydrochloride)

auxiliary substances: diluted hydrochloric acid, water for injection.

Ipigrix №10 Indications
Diseases of the peripheral nervous system: mono- and polyneuropathy, polyradiculopathy, myasthenia gravis and myasthenic syndrome of various etiologies;
diseases of the central nervous system: bulbar paralysis and paresis; the recovery period of organic lesions of the central nervous system, accompanied by movement disorders.

Ipigrix №10 Contraindications
Hypersensitivity to ipidacrine or other components of the drug
epilepsy
extrapyramidal disorders with hyperkinesis;
angina pectoris, severe bradycardia
bronchial asthma;
vestibular disorders;
peptic ulcer of the stomach or duodenum in the acute stage;
mechanical obstruction of the intestines and urinary tract.

Method of administration and dosage
Doses and duration of treatment are determined individually, depending on the severity of the disease. Solutions of ipidacrine containing 5 mg / ml and 15 mg / ml are administered intramuscularly or subcutaneously.

Diseases of the peripheral nervous system

Mono- and polyneuropathies of various origins: subcutaneously or intramuscularly inject 5-15 mg 1-2 times a day, the course of treatment is 10-15 days (in severe cases – up to 30 days), then the treatment is continued with the tablet form of the drug.

Myasthenia gravis and myasthenic syndrome: 5-30 mg is injected subcutaneously or intramuscularly 1-3 times a day, followed by a transition to a tablet form. The general course of treatment is 1-2 months. If necessary, the treatment can be repeated several times with a break between courses of 1-2 months.

Diseases of the central nervous system

Bulbar paralysis and paresis: 5-15 mg is injected subcutaneously and intramuscularly 1-2 times a day, the course of treatment is 10-15 days, if possible, switch to a tablet form.

The recovery period for organic lesions of the central nervous system.

Intramuscularly – 10-15 mg 1-2 times a day, the course of treatment – up to 15 days, then, if possible – 1-2 times a day.

Children

Due to the lack of data on the safety of using the drug Ipigrix®, solution for injection, children, the drug is not prescribed to patients of this age category.